首页 | 本学科首页   官方微博 | 高级检索  
     

中国医药上市公司并购绩效衡量——基于DEA的分析
引用本文:李栋华,邱岚,卞鹰. 中国医药上市公司并购绩效衡量——基于DEA的分析[J]. 改革与战略, 2008, 24(10)
作者姓名:李栋华  邱岚  卞鹰
作者单位:澳门大学中华医药研究院,澳门,500400;北京师范大学珠海分校,广东,珠海,519000
摘    要:对并购绩效的评价是公司并购的一项重要内容.文章将DEA方法引入到对公司并购绩效的评价中,以我国医药上市公司为对象,对样本公司并购前后运营绩效进行全面评价.研究表明,并购当年及并购后的前三年公司运营绩效呈下降趋势,第四年才有所改观.总体上看,并购后公司整体运营绩效相对于并购前有显著的下降,并购降低了公司的运营效率.

关 键 词:医药上市公司  并购  数据包络分析(DEA)  运营效率

The M & A Performance of the Listing Medical Companies in China--Based on DEA Analysis
Li Donghua,Qiu Lan,Bian Ying. The M & A Performance of the Listing Medical Companies in China--Based on DEA Analysis[J]. Reformation & Strategy, 2008, 24(10)
Authors:Li Donghua  Qiu Lan  Bian Ying
Affiliation:Li Donghua 1,Qiu Lan 2,Bian Ying (1.Chinese Traditional Medicine Institute,University of Macao,Macao 500400,2. Zhuhai School,Beijing Normal University,Zhuhai,Guangdong 519000)
Abstract:The evaluation of performance is an important content of company M & A. this paper introduces the DEA method into the evaluation of M & A performance in the companies, by taking the listing medical companies as example, makes a whole evaluation on the companies' performance before and after M & A. the result shows that the year of M & A and the after three years, the performance of company is downhill and turn better in the fourth year. From the whole, the performance of companies' operation is downwards af...
Keywords:listing medical companies  M & A  DEA  operation rate  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号